Costco Wholesale Corporation vs BIO-TECHNE Corp — how do they compare? Costco Wholesale Corporation trades at $943.85 (market cap $422.52B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Costco Wholesale Corporation is far larger — about 37.6× BIO-TECHNE Corp's market cap, and Costco Wholesale Corporation pays the higher dividend (0.62%). Which is the better fit depends on your goals.
| COST | TECH | |
|---|---|---|
Market Cap | $422.52B | $11.24B |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $72.29 |
52-Week Low | $849.63 | $43.31 |
Enterprise Value | $410.66B | $11.32B |
Dividend Yield | 0.62% | 0.44% |
Signals from Pluang's Aura AI — not financial advice
Costco Wholesale Corporation (COST) trades at $944.32, down 0.37% on the day, with a neutral technical signal and mixed earnings history. The company reported strong March 2026 sales growth of 11.3% year-over-year, reaching $28.41 billion, and maintains solid fundamentals with revenue growth and consistent profitability. Analyst consensus is strongly bullish with a $1,120 price target, supported by recent institutional buying activity.
The outlook remains positive given membership fee increases and expansion potential, but high valuation multiples like a P/E of 47.93 pose risks if growth slows. Competitive pressures and economic sensitivity are key watchpoints for investors seeking long-term value in this resilient retailer.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Trailing returns across standard periods
Latest headlines on both assets
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →